FDA WARNING_LETTER - New Life Pharma Limited Liability Company - February 13, 2026

FDA WARNING_LETTER for New Life Pharma Limited Liability Company on February 13, 2026. Product: drugs. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for New Life Pharma Limited Liability Company on February 13, 2026. Product: drugs. Access full analysis and detailed observations.

Violation Codes

21 U.S.C. 360(j)

21 U.S.C. 321(p)

FD&C Act 501(a)(2)(B)

FD&C Act 502(o)

FD&C Act 510(k)

21 U.S.C. 331(dd)

21 U.S.C. 331(a)

21 CFR 207

21 U.S.C. 360

FD&C Act 201(p)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

New Life Pharma Limited Liability Company

Inspection Date

February 13, 2026

Product Type

drugs

Office

Office of Compliance

People

Jill P. Furman (Director)

ID: 9290ade5-4491-4196-bf9c-13d39396d940

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox